We are live on ! Find out more
GRNAW

GreenLight Biosciences Holdings, PBC Warrant

Delisted

GRNAW was delisted on the 21st of July, 2023.

19 hedge funds and large institutions have $3.77M invested in GreenLight Biosciences Holdings, PBC Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0% more funds holding

Funds holding: 1919 (0)

51% less capital invested

Capital invested by funds: $7.77M → $3.77M (-$3.99M)

Holders
19
Holders Change
Holders Change %
0%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
Calls
$10K
Puts
Net Calls
+$10K
Net Calls Change
-$777K

GRNAW Hedge Fund Activity: Q4 2022 in Review

19 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Warrant (GRNAW) for Q4 2022, worth a combined $3.77M — down 51% from $7.77M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new GRNAW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Walleye Capital, adding an estimated $2.67K. The largest seller was Rockefeller Capital Management, cutting an estimated $466.

  • 19 institutional investors held GreenLight Biosciences Holdings, PBC Warrant (GRNAW) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $3.77M of GreenLight Biosciences Holdings, PBC Warrant stock for Q4 2022, down 51% quarter-over-quarter.
  • 1 fund opened new GreenLight Biosciences Holdings, PBC Warrant positions in Q4 2022 and 0 closed out, a net change of +1 holder.
  • The largest GreenLight Biosciences Holdings, PBC Warrant buyer in Q4 2022 was Walleye Capital, an estimated $2.67K added.
  • The largest GreenLight Biosciences Holdings, PBC Warrant seller in Q4 2022 was Rockefeller Capital Management, an estimated $466 sold.

Based on aggregated 13F filings for Q4 2022.